Latest Articles

Publication Date
Mum of three misdiagnosed by her GP over the phone dies just weeks later - The Mirror

Mum of three misdiagnosed by her GP over the phone dies just weeks later The Mirror

Published: Oct. 31, 2024, 9:47 p.m.
Young mum misdiagnosed in phone call dies three days after getting cancer prognosis - Daily Record

Young mum misdiagnosed in phone call dies three days after getting cancer prognosis Daily Record

Published: Oct. 31, 2024, 9:04 p.m.
Mum-of-three, 33, misdiagnosed by GP over phone call dies just weeks later - Manchester Evening News

Mum-of-three, 33, misdiagnosed by GP over phone call dies just weeks later Manchester Evening News

Published: Oct. 31, 2024, 4:11 p.m.
Over 80% of women have had their pain dismissed by a healthcare professional - MSN

Over 80% of women have had their pain dismissed by a healthcare professional MSN

Published: Oct. 28, 2024, 1:11 p.m.
‘Medical misogyny’ nightmare called out - news.com.au

‘Medical misogyny’ nightmare called out news.com.au

Published: Oct. 28, 2024, 12:18 p.m.
Women with Endometriosis Often Miss School and Work Due to Pain - Pain News Network

Women with Endometriosis Often Miss School and Work Due to Pain Pain News Network

Published: Oct. 28, 2024, 7:01 a.m.
HopeMed's Breakthrough in Endometriosis Treatment: A Promising Step Forward - Devdiscourse

HopeMed's Breakthrough in Endometriosis Treatment: A Promising Step Forward Devdiscourse

Published: Oct. 25, 2024, 5:14 a.m.
Merck’s KEYTRUDA® (pembrolizumab) Receives 30th Approval From European Commission With Two New Indications in Gynecologic Cancers - BioSpace

Merck’s KEYTRUDA® (pembrolizumab) Receives 30th Approval From European Commission With Two New Indications in Gynecologic Cancers BioSpace

Published: Oct. 24, 2024, 11:46 a.m.
Approval From European Commission With Two New Indications in Gynecologic Cancers - businesswire.com

Approval From European Commission With Two New Indications in Gynecologic Cancers businesswire.com

Published: Oct. 24, 2024, 10:45 a.m.
ASCO Reading Room | Alessandro Santin, MD, on a Promising ADC for Refractory Endometrial Cancer - Medpage Today

ASCO Reading Room | Alessandro Santin, MD, on a Promising ADC for Refractory Endometrial Cancer Medpage Today

Published: Oct. 23, 2024, 2:47 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!